Search research articles
Contact Us
Filters
Showing results (591-600 of 602) with videos related to
Page
of 61
Sort By:
Frontiers in Oncology
|
June 6, 2019
Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials
Ramy Gadalla, Babak Noamani, Bethany L MacLeod, et al.
Journal of Medicinal Chemistry
|
November 21, 2025
In Situ Ferroptosis with Global Dynamics Visualization for Glioblastoma Theranostics
Rajneesh Mungur, Ping Han, Jun Gu, et al.
Nature Communications
|
February 6, 2024
Synchrony of Bird Migration with Global Dispersal of Avian Influenza Reveals Exposed Bird Orders
Qiqi Yang, Ben Wang, Phillipe Lemey, et al.
Science (New York, N.Y.)
|
April 3, 2020
An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China
Huaiyu Tian, Yonghong Liu, Yidan Li, et al.
The Analyst
|
October 13, 2010
ToF-SIMS imaging of the nanoscale phase separation in polymeric light emitting diodes: effect of nanostructure on device efficiency
Bang-Ying Yu, Che-Hung Kuo, Wei-Ben Wang, et al.
Science Advances
|
January 31, 2024
tPA-anchored nanorobots for in vivo arterial recanalization at submillimeter-scale segments
Ben Wang, Qinglong Wang, Kai Fung Chan, et al.
Journal for Immunotherapy of Cancer
|
June 15, 2022
Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab
Geoffrey Alan Watson, Enrique Sanz-Garcia, Wen-Jiang Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 21, 2023
Highly Mimetic Ex Vivo Lung-Cancer Spheroid-Based Physiological Model for Clinical Precision Therapeutics
Ming-You Shie, Hsin-Yuan Fang, Kai-Wen Kan, et al.
Cell
|
March 6, 2026
Metabolite-gated vascular contractility switch: OXGR1 activation mechanism enables agonist therapy for rosacea erythema
Wenqin Xiao, Yan Zhu, Xinjie Tang, et al.
Journal for Immunotherapy of Cancer
|
August 6, 2020
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors
Kirsty Taylor, Helen Loo Yau, Ankur Chakravarthy, et al.
Page
of 61
Search research articles
Search
Showing results (591-600 of 602) with videos related to
Sort By:
Page
of 61
Frontiers in Oncology
|
June 6, 2019
Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials
Ramy Gadalla, Babak Noamani, Bethany L MacLeod, et al.
Journal of Medicinal Chemistry
|
November 21, 2025
In Situ Ferroptosis with Global Dynamics Visualization for Glioblastoma Theranostics
Rajneesh Mungur, Ping Han, Jun Gu, et al.
Nature Communications
|
February 6, 2024
Synchrony of Bird Migration with Global Dispersal of Avian Influenza Reveals Exposed Bird Orders
Qiqi Yang, Ben Wang, Phillipe Lemey, et al.
Science (New York, N.Y.)
|
April 3, 2020
An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China
Huaiyu Tian, Yonghong Liu, Yidan Li, et al.
The Analyst
|
October 13, 2010
ToF-SIMS imaging of the nanoscale phase separation in polymeric light emitting diodes: effect of nanostructure on device efficiency
Bang-Ying Yu, Che-Hung Kuo, Wei-Ben Wang, et al.
Science Advances
|
January 31, 2024
tPA-anchored nanorobots for in vivo arterial recanalization at submillimeter-scale segments
Ben Wang, Qinglong Wang, Kai Fung Chan, et al.
Journal for Immunotherapy of Cancer
|
June 15, 2022
Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab
Geoffrey Alan Watson, Enrique Sanz-Garcia, Wen-Jiang Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 21, 2023
Highly Mimetic Ex Vivo Lung-Cancer Spheroid-Based Physiological Model for Clinical Precision Therapeutics
Ming-You Shie, Hsin-Yuan Fang, Kai-Wen Kan, et al.
Cell
|
March 6, 2026
Metabolite-gated vascular contractility switch: OXGR1 activation mechanism enables agonist therapy for rosacea erythema
Wenqin Xiao, Yan Zhu, Xinjie Tang, et al.
Journal for Immunotherapy of Cancer
|
August 6, 2020
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors
Kirsty Taylor, Helen Loo Yau, Ankur Chakravarthy, et al.
Page
of 61